Related Experiment Video
Updated: Nov 16, 2025

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
Published on: July 14, 2023
Cardiovascular complications in COVID-19 patients with or without diabetes mellitus
Temidayo Abe1, Obiora Egbuche2, Joseph Igwe1
1Internal Medicine Residency Program, Morehouse School of Medicine, Atlanta, GA, USA.
Insights
Patients with diabetes mellitus (DM) face significantly higher risks of severe cardiovascular complications from COVID-19. This study highlights increased odds of heart failure and other cardiac events in diabetic individuals infected with the virus.
Area of Science:
- Cardiology
- Infectious Diseases
- Endocrinology
Background:
- Coronavirus disease 2019 (COVID-19) presents a global health crisis.
- Preliminary data suggest worse outcomes for patients with diabetes mellitus (DM).
- The specific magnitude of cardiovascular complications in diabetic COVID-19 patients remains unclear.
Purpose of the Study:
- To elucidate the cardiovascular (CV) complications in diabetic patients with COVID-19.
- To compare the incidence of specific CV outcomes between diabetic and non-diabetic COVID-19 patients.
- To determine the adjusted odds of CV events in diabetic COVID-19 patients.
Main Methods:
- A cohort of 142 patients with laboratory-confirmed COVID-19 was analyzed.
- 71 patients (50%) had a diagnosis of diabetes mellitus (DM).
- Multivariate logistic regression was used to compare outcomes, adjusting for age, sex, and glycemic control.
Main Results:
- Diabetic patients exhibited significantly higher unadjusted rates for composite cardiovascular endpoints (73.2% vs. 40.6%), acute myocarditis (36.6% vs. 15.5%), acute heart failure (25.3% vs. 5.6%), acute myocardial infarction (9.9% vs. 1.4%), and new-onset atrial fibrillation (12.7% vs. 1.4%).
- After adjusting for confounding variables, DM patients had increased odds of composite cardiovascular endpoint, acute heart failure, and new-onset atrial fibrillation.
- Mean age of the cohort was 58 years.
Conclusions:
- Diabetes mellitus is associated with a substantially increased risk of cardiovascular complications following COVID-19 infection.
- Diabetic patients with COVID-19 are more likely to experience adverse cardiac events, including heart failure and atrial fibrillation.
- These findings underscore the importance of close cardiovascular monitoring in diabetic individuals diagnosed with COVID-19.
Introduction:
Coronavirus disease 2019 (COVID-19) has become a major global crisis. Preliminary reports have, in general, indicated worse outcomes in diabetes mellitus (DM) patients, but the magnitude of cardiovascular (CV) complications in this subgroup has not been elucidated.
Methods:
We included 142 patients admitted with laboratory-confirmed COVID-19 from April 1st to May 30th 2020; 71 (50%) had DM. We compared baseline demographics and study outcomes between those with or without DM using descriptive statistics. Multivariate logistic regression was used to estimate the adjusted odds ratio for the study outcomes in DM patients, compared to those without DM, stratified by age, sex and glycaemic control. CV outcomes of interest include acute myocarditis, acute heart failure, acute myocardial infarction, new-onset atrial fibrillation and composite cardiovascular end-point consisting of all individual outcomes above.
Result:
Mean age was 58 years. The unadjusted rates were higher in DM patients compared to non-diabetics for the composite cardiovascular end-point (73.2% vs. 40.6% p < .0001), acute myocarditis (36.6% vs. 15.5% p = .004), acute heart failure (25.3% vs. 5.6% p = .001), acute myocardial infarction (9.9% vs. 1.4% p = .03) and new-onset atrial fibrillation (12.7% vs. 1.4% p = .009). After controlling for relevant confounding variables, diabetic patients had higher odds of composite cardiovascular end-point, acute heart failure and new-onset atrial fibrillation.
More Related Videos
Related Concept Videos
Diabetes: Symptoms, Diagnosis, and Complications
Coronary Artery Disease III: Clinical Manifestations
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Type 2 and Gestational
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Cardiomyopathy II: Dilated Cardiomyopathy

